Area of research
Hematology · Physiology
Research interest
Research interests include Blood groups and transfusion, Erythrocyte Function and Pathophysiology, Blood disorders and treatments, and Acute Myeloid Leukemia Research.
Sutimlimab vs B-Cell-Targeted Therapy in Cold Agglutinin Disease: Which Is the Optimal Approach?
Thrombosis in paroxysmal nocturnal hemoglobinuria in the complement inhibitor era: mechanisms, risk stratification, and clinical management.
Effect of obexelimab on the production of anti-RBC antibodies and cytokines in patients with warm autoimmune hemolytic anemia.
Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.
Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphoma.
Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study.
Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemia.
Breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria throughout clinical trials: from definition to clinical practice.
Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World.
Real-world evidence of pegcetacoplan in patients with paroxysmal nocturnal haemoglobinuria: A nationwide Italian study.
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study.
Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience.
Autoimmune Complications of Lymphoproliferative Diseases.
Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing.
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers.
Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease.
Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapy.
Recombinant erythropoietin in autoimmune hemolytic anemia with inadequate bone marrow response: a prospective analysis.
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study
Glycolytic activity and in vitro effect of the pyruvate kinase activator AG-946 in red blood cells from low-risk myelodysplastic syndromes patients: A proof-of-concept study.
Pregnancy in acquired bone marrow failure syndromes: Antenatal management and maternal and fetal outcomes.
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function.
COVID-19 vaccine safety and immunogenicity in patients with cold agglutinin disease receiving concomitant sutimlimab.
Diagnosis of Diamond-Blackfan anemia in adulthood: case series and review of the literature.
Deciphering cytopenias in internal medicine: a single-center observational study.
Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET survey.
Incidence of Infections and Prophylaxis Practice, in Two Cohorts of Patients of Autoimmune Disorders of Hematological Interest or Non-Hodgkin Lymphoma Treated with Rituximab
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS).
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study
Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts